baber/WOPTO huggingface dataset:
Patent NZ-219806-A (NZ)
Title: Female portion of quickly attachable hose coupling
Inventor: LEMELSHTRICH NOAM
IPC: F16L37/08
Filed: 1987-03-30
Abstract: A female connector member (4) for use in a quickly-attachable connector assembly with a male connector member (6) comprises a housing (10) formed with a socket for receiving the male connector member (6) and further formed with a pair of circumferentially-spaced openings (22) through a wall leading into said socket; and a locking member (8) having a flexible arcuate section (30) received on the outer face of the housing (10), and a pair of locking elements (32) normally projecting through the openings (22) into the socket for locking the male connector member (6) therein. The outer faces of the locking elements (32) are inclined at an acute angle to the longitudinal axis of the socket and converge in the direction of the mouth of the socket, such as not only to facilitate the insertion of the male connector member (6) into the socket by a small push force but also to lock the male connector member (6) against withdrawal from the socket even by a large pull force.
Patent NZ-225955-A (NZ)
Title: Imidazo benzodiazepine derivatives, intermediates and pharmaceutical compositions
Inventor: GARDNER CHARLES ROBERT
IPC: C07D487/14
Filed: 1988-08-26
Abstract: A compound selected from the group consisting a compound of the formula    <IMAGE>  I  wherein R1 is selected from the group consisting of phenyl, cycloalkyl of 4 to 6 carbon atoms and   <IMAGE> R4 and R5 are individually hydrogen or alkyl of 1 to 5 carbon atoms, R6 is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, phenyl, halogen, alkoxycarbonyl of 2 to 5 carbon atoms, cyano, amido and mono- and dialkylamido of 1 to 5 alkyl carbon atoms, R2 and R3 are individually selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms and cycloalkyl of 3 to 5 carbon atoms or taken together form alkylene of 3 to 5 carbon atoms, X and Y are individually selected form the group consisting of hydrogen, halogen, -NO2, azido, -CN, -CF3 and alkyl and alkoxy of 1 to 3 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts capable of inducing an affinity for benzodiazepine receptors and a novel process and novel intermediates for their preparation.
Patent NZ-226663-A (NZ)
Title: Prepolymer compositions prepared from at least one polyisocyanate, and both high and low molecular weight isocyanate-reactive compounds
Inventor: PARFONDRY ALAIN
IPC: C08G18/12
Filed: 1988-10-21
Abstract: A polyisocyanate prepolymer composition comprising the reaction product of  a) an organic polyisocyanate or polyisocyanate mixture b) a high molecular weight isocyanate-reactive compound or mixture thereof having a molecular weight from about 1 000 to 10 000 c) a low molecular weight isocyanate-reactive compound or mixture thereof having a molecular weight of about 60 to below 1 000 wherein the weight ratio of low to high molecular weight compounds is in the range 40-1 000.
Patent NZ-230399-A (NZ)
Title: Recombinant interferon regulatory factor-1 (irf-1) dna, hosts and method of production
Inventor: TADATSUGU TANIGUCHI
IPC: C12N15/12
Filed: 1989-08-22
Abstract: A recombinant DNA molecule coding for a protein having the activity of an interferon regulatory factor-1 (IRF-1).
Patent NZ-244725-A (NZ)
Title: Salts of hydrazones and their pharmaceutical compositions
Inventor: STANEK JAROSLAV
IPC: A61K31/185
Filed: 1992-10-14
Abstract: The invention relates to acid addition salts of bases of the formula I <IMAGE> in which A, R1, R2, R3, R4, R5, X and Z have the meanings given in the description, with an acid [PA], which denotes a mono- or polybasic acid selected from carbonic acid, alkanoic acids which are unsubstituted or monosubstituted to polysubstituted, apart from formic acid, unsubstituted acetic acid, lysine and arginine; alkenoic acids which are unsubstituted or substituted, apart from unsubstituted fumaric acid, cycloalkylcarboxylic acids, arylcarboxylic acids, aryl-lower alkylcarboxylic acids in which lower alkyl is unsubstituted or substituted, aryl-lower alkenylcarboxylic acids, heterocyclylcarboxylic acids, alkanesulphonic acids which are unsubstituted or substituted, apart from unsubstituted methanesulphonic acid, aromatic sulphonic acids, alkylsulphuric acids, N-substituted sulphamic acids, organic acids without carboxyl, sulpho, sulphate or phospho groups, and further from pyrophosphoric acid and hydrogen iodide; and tautomers thereof. The acid addition salts are employed for the treatment of disorders which respond to inhibition of S-adenosylmethionine decarboxylase.
Patent NZ-275269-A (NZ)
Title: Audio signal scrambling/descrambling, scrambled audio mixed with two fixed frequency signals
Inventor: QUAN RONALD
IPC: H04B15/00
Filed: 1994-10-18
Abstract: Audio signals are descrambled by double sideband modulating the scrambled audio signal with a modulation carrier having a carrier frequency slightly above the highest audio signal present in the scrambled audio. This produces a double sideband signal that is passed through a low pass filter which in turn is modulated by a second carrier frequency lower than the first carrier signal by equal to the offset spectrum of the original scrambled signal. The first low pass filter nulls out any residual carrier from the first modulator that results form the intermodulation of the two modulation frequencies that would be audible at its descrambler output. The modulators used are low noise switch type modulators that improve the signal to noise ratio in the descrambled signal over the previously used linear modulators. The use of switch type modulators provides a lower cost device with improved performance. A companion scrambling device uses similar techniques to provide improved performance at a lower cost.
Patent NZ-288857-A (NZ)
Title: Improving stability of biological pesticides
Inventor: LEBO STUART E
IPC: A01N63/50
Filed: 1995-06-08
Abstract: A method for producing agriculturally active substances such as pesticides to provide improved resistance to environmental degradation, especially heat and ultra-violet light. The method involves the direct reaction of an active protein toxin of a biologically derived pesticide with a UV protectant to form a stable complex having the UV protectant as an integral part of its structure. The method employs lignosulfonates, such as sulfite lignin or sulfonated lignin, or alternately sulfonated lignite, sulfonated tannins, napthalene sulfonates or other related compounds as the UV protectant.
Patent NZ-311461-A (NZ)
Title: Topical compositions for the skin comprising ceramic hydroxyapatite as a micro carrier
Inventor: MANSOURI ZAHRA
IPC: A61Q19/10
Filed: 1996-06-13
Abstract: Active materials such as herbal extracts, allantoin, citric acid, vitamins, anti-inflammatory agents, sun blocking agents, emollients or antimicrobial agents may be delivered to the skin of a subject in a composition comprising an effective amount of particular ceramic hydroxyapatite. The ceramic hydroxyapatite particles are uniform and spherical with a mean diameter of from 1 to about 10 micrometers.  The composition may optionally contain hyaluronic acid. A preferred skin cleansing and moisturizing composition, comprises Triclosan as an antimicrobial agent.
Patent NZ-313609-A (NZ)
Title: Toothbrush with head and handle portions formed from moulding process with interengaging projection and recess moulded around projection
Inventor: KRAMER HANS
IPC: A46D3/00
Filed: 1996-07-04
Abstract: PCT No. PCT/EP96/02978 Sec. 371 Date May 27, 1998 Sec. 102(e) Date May 27, 1998 PCT Filed Jul. 4, 1996 PCT Pub. No. WO97/02770 PCT Pub. Date Jan. 30, 1997This invention relates to a process for making a toothbrush comprising making a toothbrush head having at its basal end a first engagement part, then making a toothbrush grip handle from a plastics material by a handle molding process, during the handle molding process forming a second engagement part at the head end of the handle in engagement with the first engagement part, such that the engagement between the first and second engagement parts retains the head and grip handle together, and toothbrushes made by this process.
Patent NZ-314585-A (NZ)
Title: Method of treating H. Pylori associated gastroduodenal disease
Inventor: DOIDGE CHRISTOPHER VINCENT
IPC: A61K39/108
Filed: 1994-07-25
Abstract: The use of a composition comprising an immunologically effective amount of one or more Helicobacter antigen(s), optionally in association with a mucosal adjuvant, for treating Heliobacter infection in a mammalian host by generating a mucosal immune response in the infected host.
Patent NZ-330745-A (NZ)
Title: Bi-aromatic dibenzofuran derivatives for the treatment of keratin related diseases such as acne
Inventor: CHARPENTIER BRUNO
IPC: A61Q5/00
Filed: 1997-10-20
Abstract: i-aromatic compounds of Formula (I) simultaneously exhibiting a lipophilic unit derived from 1,2,3,4,4a,9b-hexahydro-1,4a,9b-trimethyl-1,4-methanodibenzofuran connected to a second aromatic nucleus via a linker containing 3 bonds. The compounds obtained exhibit pharmacological responses of retinoid agonist type, characterised by a marked effect in the fields of cell differentiation and proliferation. The compounds are suitable for use either as a topical agent or systemic agent for treating dermatological conditions linked to a disorder of keratisation, dermatological conditions having an inflammatory, viral and/or immunoallergic component, and dermal or epidermal proliferations. These compounds may be used in the treatment of degenerative diseases of the connective tissue, for controlling ageing of the skin, or treating disorders of cicatrisation. Wherein; Ar represents one of the following radicals shown in Formula (II); X represents one of the following shown in Formula (III); wherein R1 represents: (i) a hydrogen atom; (ii) the -CH3 radical; (iii) the -O-R3 radical; (iv) the -CH2-O-R3 radical; (v) the -O(CH2)m-(CO)n-R4 radical; (vi) the -CO-R5 radical; (vii) the -CO-O-R6 radical R2 is a hydrogen atom or a --(CH2)n -O-R3 radical, W is an oxygen atom, a S(O)p radical or a N-R7 radical, R3 is a hydrogen atom, a lower alkyl radical or a -CO-R9 radical, R4 is a lower alkyl radical or a heterocycle, R5 is a hydrogen atom, a lower alkyl radical or an -N(r',r") radical, in which r' and r" are identical or different, are selected from the group consisting of a hydrogen atom, a lower alkyl radical, a mono- or polyhydroxyalkyl radical, an optionally substituted aryl radical or an amino acid, and a peptide or sugar residue or alternatively r' and r", taken together, form a heterocycle, R6 is selected from the group consisting of a hydrogen atom, a linear or branched alkyl radical having from 1 to 20 carbon atoms, an alkenyl radical, a mono- or polyhydroxyalkyl radical, an optionally substituted aryl or aralkyl radical, and a sugar, amino acid or peptide residue, R7 is a hydrogen atom or a lower alkyl radical, R8 is a -(CH2)n-O-R3 radical, R9 is a hydrogen atom, a lower (lacuna) radical or an aryl radical, m is an integer equal to 1, 2 or 3, n is an integer equal to 0 or 1.
Patent NZ-331060-A (NZ)
Title: Quinoxalinediones, preparation and pharmaceutical compositions thereof
Inventor: BULL DAVID JOHN
IPC: C07D401/04
Filed: 1997-02-27
Abstract: he compounds of formula (I) and the pharmaceutically acceptable salts thereof wherein: R is an optionally substituted, optionally benzo-fused 5-membered ring heteroaryl group containing 3 or 4 nitrogen heteroatoms which is linked to the quinoxalinedione ring by a ring carbon or nitrogen atom or R is an optionally substituted, optionally benzo-fused 6-membered ring heteroaryl group containing from 1 to 3 nitrogen heteroatoms which is linked to the quinoxalinedione ring by a ring carbon atom; R1 and R2 are independently H, fluoro, chloro, bromo, alkyl or haloalkyl; R3 and R4 are independently H or alkyl or together are alkylene and p is 0, 1 or 2 are claimed. A pharmaceutical composition containing a compound of formula I useful as a NMDA receptor antagonist for treating acute neurodegenerative and chronic neurological disorders is also claimed.
Patent NZ-331761-A (NZ)
Title: Direct-acting boost-enhanced pressure regulator
Inventor: TURNEY CHRISTOPHER G
IPC: G05D16/06
Filed: 1997-03-28
Abstract: A boost-enhanced gas pressure regulator 53 consists of a bonnet 11 and a body 12 that are secured together so as to capture a diaphragm 13 between both components. An actuator 16 has a pair of downwardly extending control channels and a relief seat 32 in one component is connected to the diaphragm 13 to be moved with and by the latter. A boost/seat tube 20 has external guide surfaces 49 which serve to guide and control its movement, and it also has an internal gas flow passage 52 in which an elastomeric seat disk (21; valve member) is mounted. As gas pressure within the chamber 56 rises, as gas enters the chamber via gas inlet 61 and is not exhausted via outlet 58, the actuator 16 rises as the diaphragm rises, and the pinions 48 on the boost tube structure 20 are forced to close the valve 21 by direct engagement with downwardly extending control channels of the actuator 16.  As gas demand is increased the pressure in chamber 56 drops allowing opening of the valve 21 as the boost tube guide pinions 49A, 49B slide along the guide elements 47 provided on the inlet structure 19.
Patent NZ-333243-A (NZ)
Title: Wave collector structure with tubular collector chambers each having downwardly depending lip
Inventor: WELLS ALAN ARTHUR
IPC: F03D9/00
Filed: 1997-06-10
Abstract: A wave energy converter includes tubular collector chambers 55, 57 with outwardly and downwardly extending lips 105 and 107, below which are mouths 61, 67.  The collector includes side walls 75, 79 for channelling waves into the collector.  These walls enclose a volume of water between the lip and side walls. The movement of waves into and out of the mouths causes air pressure oscillations which are used to drive turbines in towers 119 and 121.
Patent NZ-333838-A (NZ)
Title: Polymorph II form of trovafloxcin mesylate, a lubricant, and at least 5% microcrystalline cellulose
Inventor: JOHNSON ALTON DALE
IPC: A61K9/16
Filed: 1999-01-20
Abstract: Described is a dry granulated composition comprising the polymorph II form of trovalfloxacin mesylate which has the formula 1, a lubricant and at least 5% of microcrystalline cellulose (MC).
Patent NZ-337305-A (NZ)
Title: Use of citicoline to reduce the extent of infarction subsequent to a ischemic event
Inventor: SANDAGE BOBBY WINSTONE
IPC: A61K31/7068
Filed: 1996-03-06
Abstract: Citicoline or a pharmaceutically acceptable salt thereof and optionally a second therapeutic agent is used in the manufacture of a medicament for protecting brain tissue from cerebral infarction subsequent to an ischemic event. A second therapeutic agent can be t-PA, streptokinase or urokinase.
Patent NZ-337359-A (NZ)
Title: Salad dressing comprising a sterol ester, a fat crystal inhibitor and and emulsifier or hydrocolloid
Inventor: DARTEY CLEMENCE K
IPC: A23L27/60
Filed: 1999-08-19
Abstract: A stable food emulsion is disclosed, wherein the food comprises a cholesterol reducing amount of a sterol ester; an emulsifier or a hydrocolloid; and an effective amount of a fat crystal inhibitor.  The a fat crystal inhibitor is selected from the group consisting of polyglycerol esters of fatty acids, sorbitan esters of fatty acids, and polysorbates bade from the reaction product of monoglycerides or sorbitan esters and ethylene oxides, and mixtures thereof.  The food product can be a salad dressing.  The method of preparing this food product is also disclosed.
Patent NZ-337653-A (NZ)
Title: Paper sized with 2-oxetanone sizing agent made from 6-22 carbons linked by normal and branched fatty acids
Inventor: MALMSTROEM OLOF
IPC: B41M5/52
Filed: 1998-03-11
Abstract: A method of manufacturing a paper grade containing additives under neutral or alkaline conditions, in which 2-oxetanone based size that is made from a greater number than one of fatty acids having main chain comprising 6-22 carbons linked with each other by saturated bonds and the acid(s) including at least one with a branched carbon chain is added to the pulp slurry in order to control the hydrophobicity properties and injet printability of the paper grade. The paper grade contains precipitated calcium carbonate as filler.
Patent NZ-500372-A (NZ)
Title: Delegated use of electronic signature
Inventor: SUDIA FRANK W
IPC: H04L9/32
Filed: 1996-04-19
Abstract: A delegate may electronically sign a document for a primary user using the electronic signing device of the primary user.  The device is provided to the delegate who is selected, the electronic signing device being validated for signing for a predetermined limited period of time.  The delegate can then affix the electronic signature of the primary user to a document using the validated device.
Patent NZ-501482-A (NZ)
Title: The use of epidermal growth factor as a gastrointestinal therapeutic agent
Inventor: OLSON MERLE E
IPC: A23K1/16
Filed: 1996-05-09
Abstract: Disclosed is the use of epidermal growth factor in the manufacture of a medicament for preventing or treating intestinal colonisation by a pathogen in an animal, treating or preventing gastric ulcers, treating or preventing infectious complications of short bowel syndrome, and treating or preventing infectious complications of necrotising enterocolitis. (62) Divided out of 307134
Patent NZ-502395-A (NZ)
Title: 4-Benzodioxolyl substituted pyrrolidine-3-carboxylic acid derivatives useful as endothelin antagonists
Inventor: KING STEVEN A
IPC: A61P7/02
Filed: 1998-07-27
Abstract: [2S,3R,4S]-2-(2,2-Dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)-1-(N,N-di-(n-butyl)-aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid and [2S,3R,4S]-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-[(N-butyl-N-(4-dimethylaminobutyl)-amino)carbonylmethyl]-pyrrolidine-3-carboxylic acid, a pharmaceutically acceptable salt thereof and the pharmaceutical composition thereof are useful for antagonizing the endothelin activity.
Patent NZ-503312-A (NZ)
Title: Screening apparatus of the fitzmill type
Inventor: KUHMONEN MAURI
IPC: E02F3/96
Filed: 1999-03-05
Abstract: Described is a screening apparatus (10) for screening particulate material.  The apparatus includes a frame (12) having an open bottom (14) through which screened particles can pass and a plurality of banks of blades (16A-16E) supported on the frame (12). Each bank of blades (16) is rotatable about axes of rotation (18A-18E). The blades (20) of each bank (16) are evenly spaced and arranged in a single row coincident with their respective axes of rotation (18). At least one of the banks of blades (16) is able to slide linearly along its respective axis of rotation (18) to provide a predetermined amount of axial free play. When the blades (20) are rotated and a particulate material is placed in the screen frame (12), the rotating blades (20) agitate and/or crush the material to allow particles of a size equal to or smaller than a gap formed between each of the adjacent blades to fall through the open bottom.
Patent NZ-507595-A (NZ)
Title: Patch bag with heat-shrinkable patch containing high and low density ethylene/alpha olefin copolymers
Inventor: MUDAR KIMBERLEY ANN
IPC: B65D75/00
Filed: 2000-10-17
Abstract: A patch bag comprising a heat-shrinkable patch adhered to a heat-shrinkable bag, the heat-shrinkable patch comprising a first heat-shrinkable film and the heat-shrinkable bag comprising a second heat-shrinkable film, the first heat-shrinkable film comprising: a) A first component comprising an ethylene/alpha-olefin copolymer having a density greater than about 0.915 g/cm3, present in an amount of at least about 5 present, based on a total weight of the first film; and b) A second component comprising heterogeneous ethylene/alpha-olefin copolymer having a density of less than about 0.915 g/cm3, wherein the second component is present in the first film in an amount of at least about 5 percent, based on the total weight of the first film; and wherein the first component ethylene/alpha-olefin copolymer having a density greater than about 0.915g/cm3 and the second component heterogeneous ethylene/alpha-olefin copolymer having a density of less than about 0.915 g/cm3 together make up at least 70 percent of the total weight of the first film.
Patent NZ-507945-A (NZ)
Title: Extrudable vinylidene chloride polymer compositions
Inventor: NAUMOVITZ JOHN A
IPC: C08K5/103
Filed: 1999-04-28
Abstract: A vinylidene chloride polymer composition comprising: (a) A vinylidene chloride polymer wherein the major component is a vinylidene chloride monomer and the remainder is one or more monoethylenically unsaturated monomer copolymerisable with the vinylidene chloride monomer; (b) A glycerol ester; and (c) A high viscosity silicon polymer fluid concentrate, the glycerol ester being present in an amount of from 0.05 to 10 weight percent based on the weight of the vinylidene chloride polymer composition and the silicone polymer being present in an amount of from 0.005 to 5 weight percent on the weight of the vinylidene chloride polymer composition and, optionally, an epoxidised processing aid which is not an epoxy group-containing 1,2-polybutadiene.
Patent NZ-510469-A (NZ)
Title: Injectable propofol formulations containing N-methyl pyrrolidone or 2-methyl pyrrolidone as a solvent
Inventor: KOMER GENE
IPC: A61K47/34
Filed: 1999-07-30
Abstract: An injectable anesthetic formulation comprises propofol and N-methyl pyrrolidone or 2-pyrrolidone or a mixture thereof.  The formulation can also contain a polyhydroxy alcohol such as propylene glycol.
Patent NZ-513746-A (NZ)
Title: Bone plate
Inventor: WAGNER MICHAEL
IPC: A61B17/58
Filed: 1999-03-09
Abstract: The bone plate has a top surface (1), a bottom surface (2) for contact with the bone and several holes (4) which are situated along the longitudinal axis of the plate, connecting the top surface and the bottom surface (1, 2), for receiving bone screws (11). The diameter of at least one of these holes (4) is greater in the direction of the longitudinal axis of the plate (3) than the diameter of said hole vertically in relation to the longitudinal axis of the plate (3). At least one of the holes (4) has an inner screw thread (5). This inner screw thread (5) extends over at least 180 DEG of the geometrical body that it forms. The inventive bone plate can serve as a compression plate and as a so-called internal fixator at the same time, as effectively as if the two elements were separate.
Patent NZ-514629-A (NZ)
Title: PEGylated interferon-alpha administered at about 4.5- 9.0 micrograms/kg/week as a renal cell carcinoma treatment
Inventor: ROSE ESTHER HELEN
IPC: A61P35/00
Filed: 2000-04-06
Abstract: Manufacture of a medicament for use in treating treatment-naïve as well as treatment-experienced patients having renal cell carcinoma (RCC) is disclosed. The medicament will achieve at least a partial tumour response and treatment comprises administering a therapeutically effective amount of PEGylated interferon-alpha, e.g., PEGylated interferon apha-2b as a monotherapy or in association with a therapeutically effective amount of IL- 2.